ACCD Stock Recent News
ACCD LATEST HEADLINES
NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of federal securities laws. On June 27, 2024, Accolade reported a quarterly loss of $0.35 per share.
LITTLE ROCK, Ark. , Aug. 22, 2024 /PRNewswire/ -- Celeste Health Solutions (Celeste), a new company that will focus on merging the power of data insights, technology and personalized health management, is being introduced to the market to simplify healthcare access for employees while also easing the burden for employers.
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of federal securities laws. On June 27, 2024, Accolade reported a quarterly loss of $0.35 per share.
NEW YORK, NY / ACCESSWIRE / August 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of federal securities laws. On June 27, 2024, Accolade reported a quarterly loss of $0.35 per share.
NEW YORK, NY / ACCESSWIRE / August 16, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of federal securities laws. On June 27, 2024, Accolade reported a quarterly loss of $0.35 per share.
NEW YORK, NY / ACCESSWIRE / August 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of federal securities laws. On June 27, 2024, Accolade reported a quarterly loss of $0.35 per share.
NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of federal securities laws. On June 27, 2024, Accolade reported a quarterly loss of $0.35 per share.
NEW YORK, NY / ACCESSWIRE / August 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of federal securities laws. On June 27, 2024, Accolade reported a quarterly loss of $0.35 per share.
NEW YORK, NY / ACCESSWIRE / August 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of federal securities laws. On June 27, 2024, Accolade reported a quarterly loss of $0.35 per share.
NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Accolade, Inc. ("Accolade") (NASDAQ:ACCD) concerning possible violations of federal securities laws. On June 27, 2024, Accolade reported a quarterly loss of $0.35 per share.